As IL-33 levels in tissue were shown to be correlated with disease activity, many authors have further assessed whether the upregulation of IL-33 in the mucosa of IBD patients could also be reflected by increased levels of the cytokine in sera. This evidence concerns the gene IL33 and inflammatory bowel disease.